Intelligence · Clinical Pipeline
Xenon Pharmaceuticals Pipeline
All ClinicalTrials.gov programs at Xenon Pharmaceuticals — phase, modality, and trial IDs.
- Programs
- 7
Quick answer
Xenon Pharmaceuticals has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
XEN1101 10 mg
Xenon Pharmaceuticals
Major Depressive Disorder
1 trial -
XPF-001
Xenon Pharmaceuticals
Dental Pain
1 trial -
XPF-001
Xenon Pharmaceuticals
Primary Erythromelalgia
1 trial -
XPF-002
Xenon Pharmaceuticals
Postherpetic Neuralgia
1 trial -
XPF-002
Xenon Pharmaceuticals
Primary Erythromelalgia
1 trial -
XPF-005
Xenon Pharmaceuticals
Acne Vulgaris
1 trial -
XPF-010, XPF-008, XEN1101 placebo
Xenon Pharmaceuticals
Adult focal (partial onset) epilepsy
1 trial
Frequently asked questions
How many pipeline programs does Xenon Pharmaceuticals have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs